CALLAHAN EYE FOUNDATION HOSP
1. Target Overview & Investment Thesis
CALLAHAN EYE FOUNDATION HOSP is a 6-bed suburban community hospital in JEFFERSON, AL with $92.4M in net patient revenue and a 0.8% operating margin. The hospital serves a payer mix of 19.8% Medicare, 4.7% Medicaid, and 75.5% commercial.
Thesis: Turnaround. Our ML models identify $6.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.8% to 8.2% (+736bps).
| Net Revenue HCRIS | $92.4M |
| Current EBITDA COMPUTED | $734K |
| Operating Margin COMPUTED | 0.8% |
| Occupancy HCRIS | 16.6% |
| Revenue / Bed COMPUTED | $15.4M |
| Net-to-Gross HCRIS | 30.9% |
| Distress Probability ML | 35.0% |
2. Market Context & Competitive Position
AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of 0.8% places it above the state median. Among 114 size-comparable peers (3-12 beds), the median margin is -8.7%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (3-12), prioritizing same-state peers. 114 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CALLAHAN EYE FOUNDATION HOSP (Target) | AL | 6 | $92.4M | 0.8% |
| WENATCHEE VALLEY HOSPITAL | WA | 11 | $277.5M | -4.9% |
| FRANCISCAN HEALTH HAMMOND | IN | 10 | $117.7M | -4.3% |
| OCONTO HOSPITAL & MEDICAL CENT | WI | 10 | $80.4M | 1.1% |
| SUMMIT PACIFIC MEDICAL CENTER | WA | 10 | $73.6M | 9.1% |
| PHYSICIANS MEDICAL CENTER | IN | 10 | $60.0M | 24.9% |
| SAMUEL SIMMONDS MEMORIAL HOSPI | AK | 10 | $57.8M | -50.0% |
| INSTITUTE FOR ORTHOPAEDIC SURG | OH | 12 | $55.6M | 39.5% |
| JOYCE EISENBERG KEEFER MEDICAL | CA | 10 | $52.9M | 18.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.9M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $59K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $734K |
| + RCM Uplift | +$6.8M |
| Pro Forma EBITDA | $7.5M |
| Current Margin | 0.8% |
| Pro Forma Margin | 8.2% |
| WC Released (1x) | $3.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.1M | $72.9M | 64.56x | 130.1% |
| Base (11x exit) | 10.0x | 11.0x | $1.1M | $80.5M | 71.34x | 134.8% |
| Bull Case | 9.0x | 11.0x | $1.0M | $103.4M | 101.72x | 152.0% |
| Bull (12x exit) | 9.0x | 12.0x | $1.0M | $113.1M | 111.26x | 156.6% |
| Bear Case | 11.0x | 10.0x | $1.2M | $38.5M | 31.00x | 98.7% |
| Bear (11x exit) | 11.0x | 11.0x | $1.2M | $42.7M | 34.42x | 102.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 16.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 114 hospitals with 3-12 beds
- Same-state prioritization (n=2)
- Comp margins: P25=-22.5% / P50=-8.7% / P75=2.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.